The use of high dose immunoablative therapy with hematopoietic stem cell support therapy in the treatment of severe autoimmune diseases

Int J Hematol. 2002 Aug:76 Suppl 1:218-22. doi: 10.1007/BF03165249.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / therapy*
  • Clinical Trials as Topic
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Myeloablative Agonists / therapeutic use
  • Transplantation Conditioning / methods

Substances

  • Immunosuppressive Agents
  • Myeloablative Agonists